Evolus, Inc., was incorporated in Delaware in November 2012. The company is a global efficacy beauty company focusing on the self-funded medical beauty market, providing injectable products to licensed beauty practitioners. Its main product, Jeuveau, is a purified botulinum toxin type A for temporarily improving the eyebrow lines, while the company is developing Evolysse, a series of hyaluronic acid gels for injection for facial beauty applications.
